Anavex Life Sciences Corp. (NASDAQ ... 2b/3ATTENTION-AD open-label extension trial. The data demonstrated that over three ...

The government has funded science and then largely left well enough alone. Scientific agencies have been staffed by ...

In a visit to UB, the lawmakers said cutting indirect cost reimbursement for grants would negatively impact livesaving ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

As of 2023 year-end, the firm had $1.2 billion of debt, $1.6 billion of cash and cash equivalents, and $1.5 billion of deferred taxes that are largely related to its Sartorius investment. We forecast ...

The citation index, first seeded as an embryo by the information scientist Eugene Garfield in the 1950s, was delivered in the 1960s as a fully formed child, the Science Citation Index. Its twin ...

Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

For fiscal year 2023, NIH spent more than $35 billion in about 50,000 grants to more than 300,000 researchers at more than ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Year-end Report January-December 2024. The full report is available on the Company's website. "Stronger ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Keynote Presentation. Dr. William Dahut discussed how ...